Vaccine

The College of American Pathologists Hosts 2021 Annual Meeting: September 25-28

Thursday, September 23, 2021 - 8:54pm

The College of American Pathologists (CAP) will host its CAP21 Annual Meeting with timely and informative educational sessions from Sat., Sept. 25 through Tues., Sept. 28 at the Hyatt Regency Chicago.

Key Points: 
  • The College of American Pathologists (CAP) will host its CAP21 Annual Meeting with timely and informative educational sessions from Sat., Sept. 25 through Tues., Sept. 28 at the Hyatt Regency Chicago.
  • Pathologists have been resilient as 2021 continues to be an extraordinary and remarkable year in our profession, says CAP President Emily E. Volk, MD, FCAP.
  • Pathologists oversee and provide laboratory testing and diagnose viruses, chronic diseases, cancers and other health conditions.
  • For more information, visit yourpathologist.org to watch pathologists at work and see the stories of the patients who trust them with their care.

White House COVID-19 Plan to Protect Economic Recovery Via Employer Vaccination and Diagnostic Test Tracking

Thursday, September 23, 2021 - 7:40pm

To comply with the mandate, HR professionals will now need to review and track vaccination documentation across their entire staff.

Key Points: 
  • To comply with the mandate, HR professionals will now need to review and track vaccination documentation across their entire staff.
  • For those who don't have the vaccine, have they submitted a weekly diagnostic test?
  • Included in CB COVID-19 Compliance is the company's Diagnostic Test Tracking solution, which helps organizations track the results of a diagnostic COVID-19 test via a secure, password-protected platform.
  • Located in Wilmington, N.C., CastleBranch is one of the leading providers of vaccination, immunization tracking and diagnostic test tracking in the United States.

Btein Bars, Makers of Healthy, Low-Glycemic Ayurvedic Protein Bars, Launch New Website

Thursday, September 23, 2021 - 7:18pm

PALM BEACH, FL, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Btein protein bars this week announced the launch of their new website.

Key Points: 
  • PALM BEACH, FL, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Btein protein bars this week announced the launch of their new website.
  • Btein bars contain the ancient Ayurvedic herb, Ashwagandha (also known as Withania somnifera), which has been recognized for its medicinal properties for 1000s of years.
  • Also, this herb along with the high-quality essential protein in the Btein bars helps boost immunity.
  • With our new website, we give consumers the information they need to choose a healthy, great-tasting protein bar, Saran said.

Twist Bioscience Internally-Discovered Single Domain Antibody TB202-3 Shows Potent Binding to Multiple Strains of SARS-CoV-2, Including Alpha, Beta, and Gamma Strains, in Preclinical Studies

Thursday, September 23, 2021 - 7:01pm

TB202-3 binds to a specific area (RBD-4) of the SARS-CoV-2 spike protein that has not been impacted by most viral mutations.

Key Points: 
  • TB202-3 binds to a specific area (RBD-4) of the SARS-CoV-2 spike protein that has not been impacted by most viral mutations.
  • This makes it an important and viable candidate for clinical testing in combination with other antibody therapeutics.
  • TB202-3 binds to a majority of known mutations, with the exception of the L452R mutation present in the Delta and Epsilon variants.
  • Target recognition by VHH single domains, on the other hand, requires just a single domain found on heavy chain only antibody.

Businesses are Wondering How to Meet Biden's Vaccine Mandate

Thursday, September 23, 2021 - 6:33pm

While politicians are fighting over the constitutionality of the mandate, HR managers and business owners in the 200,000 U.S. companies with one-hundred-plus employees are wondering how to implement the new guidelines.

Key Points: 
  • While politicians are fighting over the constitutionality of the mandate, HR managers and business owners in the 200,000 U.S. companies with one-hundred-plus employees are wondering how to implement the new guidelines.
  • A bevy of federal agencies are still hammering out the specifics of Biden's proposed mandate.
  • He continued by saying you can't expect companies to hire new staff qualified to deliver the vaccine or weekly testing to employees.
  • "When the President made the mandate announcement, we were already getting ready to set up fall vaccination drives.

Datatrak International, Inc. Discusses Potential of Its eClinicial and Predictive Analytics Platforms with The Stock Day Podcast

Wednesday, September 22, 2021 - 2:00pm

Phoenix, Arizona--(Newsfile Corp. - September 22, 2021) - The Stock Day Podcast welcomed Datatrak International, Inc. (OTC Pink: DTRK) ("the Company"), a software-as-a-service provider of enterprise cloud-based technologies for the life sciences industry.

Key Points: 
  • Phoenix, Arizona--(Newsfile Corp. - September 22, 2021) - The Stock Day Podcast welcomed Datatrak International, Inc. (OTC Pink: DTRK) ("the Company"), a software-as-a-service provider of enterprise cloud-based technologies for the life sciences industry.
  • CEO of the Company, Jim Bob Ward, and Chairman, Alex Tabatabai, joined Stock Day host Everett Jolly.
  • "We saw a good opportunity but a company that needed to change its direction," he added.
  • "For the last five years we have been focused on expanding the product offerings, which is now complete."

Burcon Announces Board Change and Provides Business Update

Tuesday, September 21, 2021 - 12:00pm

Burcon is also pleased to provide an update on its operations.

Key Points: 
  • Burcon is also pleased to provide an update on its operations.
  • Dr. Tyrrell served as chairman of Burcon's board of Directors since January of 2019 and has been a member of Burcon's board since 2008.
  • Mr. Peter H. Kappel was appointed as a director of Burcon in January 2016.
  • In addition to his board duties, Mr. Kappel has worked closely with management to achieve the transformational business relationships of the past few years.

Strategic Alliance with Ross Lifescience Opens the Way for Potential Fast Commercialisation of Forrest's Natural Vector Control in India

Tuesday, September 21, 2021 - 2:00pm

Ross conducts laboratory as well as field trials for evaluating the efficacy of various products to control insect pests.

Key Points: 
  • Ross conducts laboratory as well as field trials for evaluating the efficacy of various products to control insect pests.
  • Under the Public health activities, Ross conducts multi-location field trials to test the efficacy of products.
  • Ross also produces and markets products in the mosquito-transmitted disease sector and has extensive distribution expertise throughout India.
  • Forrest's proprietary technology, Natural Vector Control (NVC), is commercially approved.

Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Incyte for Tafasitamab and Pemigatinib in Latin America

Thursday, September 23, 2021 - 12:30pm

Under the terms of the agreement, Incyte will be responsible for the development, manufacture and supply to Knight of tafasitamab and pemigatinib, and Knight will be responsible for seeking the necessary regulatory approvals and distributing both medicines in Latin America.

Key Points: 
  • Under the terms of the agreement, Incyte will be responsible for the development, manufacture and supply to Knight of tafasitamab and pemigatinib, and Knight will be responsible for seeking the necessary regulatory approvals and distributing both medicines in Latin America.
  • We are delighted to partner with Incyte, a leading global biopharmaceutical company, to bring tafasitamab and pemigatinib to patients in Latin America upon approval, said Samira Sakhia, President and Chief Executive Officer of Knight.
  • We are eager to work together to expand access to tafasitamab and pemigatinib so that eligible patients in Latin America have access to these innovative medicines.
  • In January 2020, MorphoSys and Incyte entered into a collaboration and licensing agreement to further develop and commercialize tafasitamab globally.

Celldex Announces Upcoming Presentation of CDX-0159 Phase 1b Results in Inducible Urticaria at the 2021 European Academy of Dermatology and Venereology (EADV) 30th Congress

Thursday, September 23, 2021 - 1:01pm

CDX-0159 is a humanized monoclonal antibody that specifically binds the receptor tyrosine kinase KIT with high specificity and potently inhibits its activity.

Key Points: 
  • CDX-0159 is a humanized monoclonal antibody that specifically binds the receptor tyrosine kinase KIT with high specificity and potently inhibits its activity.
  • KIT is expressed in a variety of cells, including mast cells, which mediate inflammatory responses such as hypersensitivity and allergic reactions.
  • In certain inflammatory diseases, such as chronic urticaria, mast cell activation plays a central role in the onset and progression of the disease.
  • Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate.